Related Experiment Video
Updated: Feb 15, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
Irina Fadejeva1, Horst Olschewski1,2, Andelko Hrzenjak1,2
1Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Abstract:
With more than 80% of all diagnosed lung cancer cases, non-small cell lung cancer (NSCLC) remains the leading cause of cancer death worldwide. Exact diagnosis is mostly very late and advanced-stage NSCLCs are inoperable at admission. Tailored therapies with tyrosine kinase inhibitors are only available for a minority of patients. Thus, chemotherapy is often the treatment of choice. As first-line chemotherapy for NSCLCs, platinum-based substances (e.g. cisplatin, CDDP) are mainly used. Unfortunately, the positive effects of CDDP are frequently diminished due to development of drug resistance and negative influence of microenvironmental factors like hypoxia. MicroRNAs (miRNAs) are small, non-coding molecules involved in the regulation of gene expression and modification of biological processes like cell proliferation, apoptosis and cell response to chemotherapeutics. Expression of miRNAs is often deregulated in lung cancer compared to corresponding non-malignant tissue. In this review we summarize the present knowledge about the effects of miRNAs on CDDP-resistance in NSCLCs. Further, we focus on miRNAs deregulated by hypoxia, which is an important factor in the development of CDDP-resistance in NSCLCs. This review will contribute to the general understanding of miRNA-regulated biological processes in NSCLC, with special focus on the role of miRNA in CDDP-resistance.
Insights
MicroRNAs (miRNAs) impact cisplatin (CDDP) resistance in non-small cell lung cancer (NSCLC). Hypoxia-deregulated miRNAs are key factors in developing CDDP resistance, influencing treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer death, often diagnosed at late, inoperable stages.
- Platinum-based chemotherapy, like cisplatin (CDDP), is a primary treatment, but drug resistance and hypoxia limit efficacy.
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression and cellular processes, often deregulated in NSCLC.
Purpose of the Study:
- To review the current understanding of miRNA roles in CDDP resistance in NSCLC.
- To highlight miRNAs deregulated by hypoxia and their contribution to CDDP resistance.
- To elucidate miRNA-mediated biological processes in NSCLC, focusing on CDDP resistance.
Main Methods:
- Literature review of studies on miRNAs, CDDP resistance, and hypoxia in NSCLC.
- Analysis of miRNA expression patterns in NSCLC and their correlation with treatment response.
- Synthesis of current knowledge on miRNA-mediated mechanisms of CDDP resistance.
Main Results:
- miRNAs significantly influence the development of CDDP resistance in NSCLC.
- Hypoxia is a critical microenvironmental factor that deregulates specific miRNAs, promoting CDDP resistance.
- Understanding these miRNA alterations is crucial for predicting and overcoming treatment resistance.
Conclusions:
- miRNAs are key regulators of CDDP resistance in NSCLC, particularly under hypoxic conditions.
- Targeting specific miRNAs or pathways affected by hypoxia may offer novel therapeutic strategies.
- Further research into miRNA function in NSCLC can improve treatment efficacy and patient outcomes.
Related Concept Videos
MicroRNAs
MicroRNAs
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Lung Capacity
Hormonal Regulation

